Chris Danes, Scientific Director, US Medical Affairs for Lung Cancer, Takeda Oncology
Advertisement
Articles by Chris Danes, Scientific Director, US Medical Affairs for Lung Cancer, Takeda Oncology
Advertisement
Latest Updated Articles
- Bringing Precision Medicine to Community Oncology is Going to Require Bigger Thinking
Published: May 23rd 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5